Skip to content

LSD-Like Panic From Risperidone in Post-LSD Visual Disorder

Henry David Abraham, Anitra Mamen

Journal of Clinical Psychopharmacology June 1, 1996 DOI: 10.1097/00004714-199606000-00008 via OpenAlex

Summary

AI-generated from the abstract

Risperidone, a medication that blocks serotonin-2 and dopamine D2 receptors, worsened symptoms in three patients with hallucinogen-persisting perception disorder (HPPD), a condition sometimes triggered by LSD that causes ongoing visual disturbances and panic. The exacerbation of LSD-like panic and visual symptoms suggests that HPPD may be a relative contraindication for risperidone use.

Study at a glance

Characteristics Case study Case report Peer reviewed
Sample size 3
Population Patients with hallucinogen-persisting perception disorder (HPPD)
Intervention Risperidone
Topics Anxiety
Keywords Risperidone Medicine Psychology Psychiatry
Citations 50
Key finding Three HPPD patients treated with risperidone reported an exacerbation of LSD-like panic and visual symptoms.

Abstract

Risperidone, a novel antipsychotic agent, is an antagonist of postsynaptic serotonin-2 and dopamine D2 receptors. In certain individuals, the hallucinogenic drug lysergic acid diethylamide (LSD) is associated with apparently lifelong continuous visual disturbances, characterized in DSM-IV as hallucinogen-persisting perception disorder (HPPD). Because the hallucinogenic mechanism of LSD is known to act in part at postsynaptic serotonin-2 receptors, it is noteworthy that three HPPD patients treated with risperidone reported an exacerbation of LSD-like panic and visual symptoms. We conclude that HPPD may be a relative contraindication for the use of risperidone.

Explore topics

Comments

No comments yet.

Log in to comment